Epidermal growth factor levels are related to diastolic blood pressure and carotid artery stiffness

被引:5
作者
Lundstam, Ulf
Hagg, Ulrika
Sverrisdottir, Y. R. S. A. Bergmann
Svensson, Lennart E. T.
Gan, Li-Ming
机构
[1] Univ Gothenburg, Inst Physiol & Pharmacol, Dept Physiol, Sahlgrenska Acad, Gothenburg 40530, Sweden
[2] Univ Gothenburg, Inst Cardiovasc Dis, Dept Clin Physiol, Sahlgrenska Acad, Gothenburg 40530, Sweden
[3] AstraZeneca, R&D, Molndal, Sweden
关键词
eGF; diastolic blood pressure; CCA stiffness;
D O I
10.1080/14017430701439508
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. The epidermal growth factor ( EGF) is believed to be involved in vascular remodelling. EGF receptors are expressed in human atherosclerotic tissue. Design. In order to study the role of EGF in vascular remodelling and early progression of atherosclerosis, 17 men and 16 women aged 20 to 45 years were recruited. Common Carotid Artery Stiffness index ( CCA SI) and blood pressure were evaluated. In addition, serum levels of EGF and blood lipids were measured. Results. The levels of serum EGF were significantly correlated to diastolic blood pressure ( p < 0.05) and CCA SI ( p < 0.05). Subjects with EGF concentrations in the upper median had significantly lower levels of HDL ( High Density Lipoproteins) ( p < 0.05) and ApoA1 ( Apolipoprotein) ( p < 0.05) than those with EGF concentrations in the lower median. Discussion. High serum level of EGF is associated with elevated diastolic blood pressure and increased vessel stiffness suggesting a possible functional role of EGF in the cardiovascular system in a healthy population.
引用
收藏
页码:308 / 312
页数:5
相关论文
共 25 条
  • [1] ApoA1 reduces free cholesterol accumulation in atherosclerotic lesions of ApoE-deficient mice transplanted with ApoE-expressing macrophages
    Boisvert, WA
    Black, AS
    Curtiss, LK
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (03) : 525 - 530
  • [2] Tranilast attenuates vascular hypertrophy, matrix accumulation and growth factor overexpression in experimental diabetes
    Bonnet, F
    Cao, Z
    Cooper, ME
    Cox, AJ
    Kelly, DJ
    Gilbert, RE
    [J]. DIABETES & METABOLISM, 2003, 29 (04) : 386 - 392
  • [3] LOCALLY ACTING GROWTH-FACTORS FOR VASCULAR SMOOTH-MUSCLE CELLS - ENDOGENOUS SYNTHESIS AND RELEASE FROM PLATELETS
    BOWENPOPE, DF
    ROSS, R
    SEIFERT, RA
    [J]. CIRCULATION, 1985, 72 (04) : 735 - 740
  • [4] Pulse pressure - A review of mechanisms and clinical relevance
    Dart, AM
    Kingwell, BA
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (04) : 975 - 984
  • [5] The epidermal growth factor receptors and their family of ligands: Their putative role in atherogenesis
    Dreux, AC
    Lamb, DJ
    Modjtahedi, H
    Ferns, GAA
    [J]. ATHEROSCLEROSIS, 2006, 186 (01) : 38 - 53
  • [6] Fernández G, 2000, CELL STRESS CHAPERON, V5, P306, DOI 10.1379/1466-1268(2000)005<0306:ISICFA>2.0.CO
  • [7] 2
  • [8] Development of a high-throughput automated analyzer using biochip array technology
    FitzGerald, SP
    Lamont, JV
    McConnell, RI
    Benchikh, EO
    [J]. CLINICAL CHEMISTRY, 2005, 51 (07) : 1165 - 1176
  • [9] Epidermal growth factor: a potent vasoconstrictor in experimental hypertension
    Florian, JA
    Watts, SW
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1999, 276 (03): : H976 - H983
  • [10] Folkow B, 1995, J HYPERTENS, V13, P1546